Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Sign Up to like & getrecommendations! Published in 2023 at "European journal of cancer"
DOI: 10.2139/ssrn.4355576
Abstract: BACKGROUND Renal medullary carcinoma (RMC) and collecting duct carcinoma (CDC) are rare entities with a poor outcome. First-line metastatic treatment is based on gemcitabine + platinum chemotherapy (GC) regimen but retrospective data suggest enhanced anti-tumour activity with the… read more here.
Keywords: collecting duct; rmc cdc; cdc; trial ... See more keywords